At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Apr 13, 2026 at 07:00 ET
ImageneBio (IMA) announced a $30 million private placement led by Coastlands Capital, with proceeds aimed at advancing its IMG-007 program in alopecia areata and atopic dermatitis. The offering includes pre-funded warrants exercisable at $0.001 per share, representing immediate economic dilution to existing shareholders.
- ImageneBio raised approximately $30 million in a private placement through pre-funded warrants.
- Pre-funded warrants for 5,770,335 shares were sold at $5.199 per unit, exercisable at $0.001 per share.
- Proceeds will fund development of IMG-007 in alopecia areata and late-stage atopic dermatitis trials.
- The placement was led by new investor Coastlands Capital, with participation from Trails Edge Capital, Omega Funds, and OrbiMed.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access